Twenty Years of G-CSF

Clinical and Nonclinical Discoveries

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Medical Science, Pharmacology
Cover of the book Twenty Years of G-CSF by , Springer Basel
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783034802185
Publisher: Springer Basel Publication: January 5, 2012
Imprint: Springer Language: English
Author:
ISBN: 9783034802185
Publisher: Springer Basel
Publication: January 5, 2012
Imprint: Springer
Language: English

Granulocyte colony-stimulating factor (G-CSF or GCSF) is a secreted glycoprotein that stimulates the proliferation and differentiation of granulocyte precursor cells, and induces mobilization of peripheral blood progenitor cells from the bone marrow. Development of recombinant human G-CSF has had a profound impact on the treatment of many diseases, including severe chronic neutropenia and cancer, and has enabled peripheral stem cell transplantation to supplant bone marrow transplantation in the autologous setting.

This Milestones in Drug Therapy volume describes the experience of the last 20 years of treatment with recombinant human G-CSF, including the basic science, the use of recombinant human G-CSF in both the oncology and nononcology settings, and the safety and economics of its use. Many of the authors were the original investigators of recombinant human G-CSF and other authors are key researchers who provide their outlook for the next 20 years for use of and research with recombinant human G-CSF.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Granulocyte colony-stimulating factor (G-CSF or GCSF) is a secreted glycoprotein that stimulates the proliferation and differentiation of granulocyte precursor cells, and induces mobilization of peripheral blood progenitor cells from the bone marrow. Development of recombinant human G-CSF has had a profound impact on the treatment of many diseases, including severe chronic neutropenia and cancer, and has enabled peripheral stem cell transplantation to supplant bone marrow transplantation in the autologous setting.

This Milestones in Drug Therapy volume describes the experience of the last 20 years of treatment with recombinant human G-CSF, including the basic science, the use of recombinant human G-CSF in both the oncology and nononcology settings, and the safety and economics of its use. Many of the authors were the original investigators of recombinant human G-CSF and other authors are key researchers who provide their outlook for the next 20 years for use of and research with recombinant human G-CSF.

More books from Springer Basel

Cover of the book Berichte zu Pflanzenschutzmitteln 2011 by
Cover of the book Drugs Targeting B-Cells in Autoimmune Diseases by
Cover of the book Isaac Newton's Temple of Solomon and his Reconstruction of Sacred Architecture by
Cover of the book Towards a General Theory of Classifications by
Cover of the book Visual Reasoning with Diagrams by
Cover of the book T Lymphocytes as Tools in Diagnostics and Immunotoxicology by
Cover of the book Control and Optimization with PDE Constraints by
Cover of the book Indacaterol by
Cover of the book The Inflammasomes by
Cover of the book Lentiviral Vectors and Gene Therapy by
Cover of the book Treatment of Cystic Fibrosis and Other Rare Lung Diseases by
Cover of the book Berichte zur Lebensmittelsicherheit 2011 by
Cover of the book Immunosenescence by
Cover of the book For Better or For Worse? Collaborative Couples in the Sciences by
Cover of the book Fluorescent Methods for Molecular Motors by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy